• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

    20.01 +1.44 (+7.75%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 529,544
    Open 18.57
    Bid (Size) 19.10 (4)
    Ask (Size) 21.00 (1)
    Prev. Close 18.57
    Today's Range 18.28 - 20.55
    52wk Range 13.30 - 30.03
    Shares Outstanding 41,151,111
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    What's going on in today's pre-market session
    Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session. 
    Via Chartmill
    Enliven Posts Loss Beat and Cash Surge
    Via The Motley Fool
    Topics Intellectual Property

    Performance

    YTD
    -16.3%
    -16.3%
    1 Month
    -3.2%
    -3.2%
    3 Month
    -3.2%
    -3.2%
    6 Month
    -5.0%
    -5.0%
    1 Year
    -17.0%
    -17.0%

    More News

    Read More
    Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    Enliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’
    Via Stocktwits
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
    Via Benzinga
    Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
    Via Benzinga
    ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
    Via Benzinga
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
    Via Benzinga
    Wall Street Mixed As Tech Stocks Fall, Fed Meeting Begins
    Via Talk Markets
    Topics Economy
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    7 A-Rated Biotech Stocks for Your August Buy List
    Via InvestorPlace
    Bears Reload On Mobileye After Sharp Gains In Stock Price
    Via Talk Markets

    Frequently Asked Questions

    Is Enliven Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Enliven Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Enliven Therapeutics, Inc. - Common Stock trade on?
    Enliven Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Enliven Therapeutics, Inc. - Common Stock?
    The ticker symbol for Enliven Therapeutics, Inc. - Common Stock is ELVN on the Nasdaq Stock Market
    What is the current price of Enliven Therapeutics, Inc. - Common Stock?
    The current price of Enliven Therapeutics, Inc. - Common Stock is 20.01
    When was Enliven Therapeutics, Inc. - Common Stock last traded?
    The last trade of Enliven Therapeutics, Inc. - Common Stock was at 09/26/25 04:00 PM ET
    What is the market capitalization of Enliven Therapeutics, Inc. - Common Stock?
    The market capitalization of Enliven Therapeutics, Inc. - Common Stock is 823.43M
    How many shares of Enliven Therapeutics, Inc. - Common Stock are outstanding?
    Enliven Therapeutics, Inc. - Common Stock has 823M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.